The Uncontrolled Epileptic Dog

 
 

Clare Rusbridge BVMS DipECVN MRCVS
 
 

1) The dog whose seizures have never been controlled
 
 

The majority of dogs with idiopathic epilepsy are treated with anticonvulsant drugs such as phenobarbitone and primidone.  Although most patients will have a satisfactory reduction in seizures, some will continue to have fits causing frustration for owners and veterinary surgeons alike.  However, many patients can be controlled.  The most common reason for inadequate seizure control is that the dog is not receiving enough anticonvulsant.  In order to prevent seizures, an anticonvulsant must be given in a sufficient amount and manner to ensure that a "therapeutic concentration" is achieved in the blood and ultimately in the brain.
 
 

The anticonvulsant must be administered at regular time intervals.  For example, phenobarbitone is usually given every 12 hours.  If the first is given at 7am then the second dose should be given at 7pm.  A delay or early administration will lead to a period of increased susceptibility to seizures.  Obviously, forgetting to administer the drug altogether is very dangerous.  At best this results in poor control;  at worse life threatening seizures can occur.
 
 

The anticonvulsant must be given adequate time to work.  It takes two weeks for phenobarbitone to achieve a steady concentration in the blood.  This means that the dog should be on the new dosage for at least two weeks before a decision can be made as to the anticonvulsant's effectiveness.  Understandably, many owners assume that the drug cannot be working if the seizures do not stop immediately.  Owners can also become concerned about the sedation of the pet from drugs such as phenobarbitone and primidone.  The owner becomes concerned that the personality of the dog has been changed and that the seizures are still not under control.  It is important to realise that although unpleasant, the sedation is not permanent and is usually only seen during the first two weeks of therapy.
 
 

The most common reason for failure of control is that the dosage of anticonvulsant is too low,  If your veterinary surgeon suspects this, he/she may measure the concentration of phenobarbitone in the dog's blood.  If the concentration is below the therapeutic range, then the dosage should be increased.  Evaluating the concentration of the drug in the blood is also an invaluable method to ensure that the dog is not receiving an overdose.
 
 

If a blood sample reveals that the phenobarbitone concentration is within the therapeutic range, but the dog is still experiencing frequent seizures, it does not necessarily mean that the anticonvulsant is ineffective for the patient.  As long as the blood concentration remains within the therapeutic range the dosage can be increased.  The frequency or number of seizures will usually decrease.  If satisfactory seizure control has not been achieved at this point then your veterinary surgeon may recommend the addition of another anticonvulsant such as potassium bromide.
 
 

An obvious reason for inadequate control is an incorrect diagnosis - i.e. the dog does not have true idiopathic epilepsy.  Idiopathic epilepsy is the term used for dogs with recurrent seizures that are not secondary to an underlying disease process.  There are many other causes of seizures.  To rule out underlying disease, your vet will take a blood sample to evaluate general organ function.  He may also recommend that a cerebrospinal fluid sample is taken and analysed and/or that the dog is referred for a CT or MRI scan.  These tests reveal inflammation in the brain and structural changes such as brain tumours.
 
 

Unfortunately there is always a proportion of dogs that continue to have frequent seizures despite adequate anticonvulsant therapy.  One study suggested that 30% of canine epileptics cannot be controlled.  Until further methods of treating epilepsy are developed there is no satisfactory method of managing these dogs.
 
 

2)  The dog whose seizures were controlled, but are now out of control
 
 

The most common reason for an increase in seizure frequency is the phenomenon of drug tolerance.  Anticonvulsants such as phenobarbitone and primidone are capable of stimulating the production of the enzymes that can break them down.  This means that the liver can break the anticonvulsant down more quickly resulting in an inadequate concentration of drug in the blood and in the brain.  If the phenobarbitone concentration in the blood is evaluated it will be below the therapeutic range.  Simply increasing the dosage should re-establish control.  The blood concentration is usually rechecked two weeks after changing the dosage to ensure the new concentration is adequate.  Many veterinary surgeons now check the epileptic dog's blood phenobarbitone concentration every six months to ensure their patient is receiving the correct dose.
 
 

Another cause of recurrence of seizures are the fluctuations of hormone levels found around the time of oestrus in the female dog - i.e. coming "on heat".  For this reason your veterinary surgeon will probably recommend that the female epileptic dog is spayed.  Concurrent disease or stress can also cause a temporary recurrence of seizures.  Vomiting and diarrhoea can lead to poor absorption of the anticonvulsant from the intestine.  Usually when the dog recovers from the illness, the seizure frequency decreases.  If seizures are associated with an identifiable cause of stress, the dosage of anticonvulsant can be temporarily increased twelve hours prior to the stressful event.  Obviously, to ensure the safety of your dog, it is vital to consult your veterinary surgeon before making any changes in anticonvulsant dosage.
 
 

The most distressing but fortunately less common cause of a recurrence of seizures is development of a second seizure causing disease.  If your veterinary surgeon suspects this he/she may recommend performing further tests such as taking blood tests, a cerebrospinal fluid sample or brain scan.
 
 

Clare Rusbridge is in private practice at The Stone Lion Veterinary Centre, 41 High Street, Wimbledon Common, London, SW19 5AU Tel: 0181-946-4228/Fax: 0181 944 0871.